Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nivalis Therapeutics Inc (NASDAQ:NVLS)

2.20
BATS BZX Real-Time Price
As of 2:15pm ET
 -0.17 / -7.17%
Today’s Change
2.02
Today|||52-Week Range
9.46
-71.58%
Year-to-Date

Today’s Trading

Previous close2.37
Today’s open2.34
Day’s range2.15 - 2.38
Volume19,688
Average volume (3 months)177,356
Market cap$31.7M
Dividend yield--
Data as of 2:15pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)-156.17%
Earnings growth (this year)+14.24%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.38

Competitors

 Today’s
change
Today’s
% change
IMMYImprimis Pharmaceuti...+0.01+0.42%
DFFNDiffusion Pharmaceut...-0.16-5.87%
MBRXMoleculin Biotech In...+0.02+0.83%
THLDThreshold Pharmaceut...+0.00+0.02%
Data as of 2:01pm ET, 12/07/2016

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$0.00
Annual profit (last year)-$22.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon Congleton
Chief Operating Officer
Janice Troha
Corporate headquarters
Boulder, Colorado

Forecasts


Search for Jobs